The researchers found that this treatment was beneficial in reducing pain while also improving quality of life. “Medical cannabis treatment with the Syqe Inhaler demonstrated overall long-term pain reductions, quality of life improvements, and opioid-sparing effects in a cohort of patients with chronic pain, using just a fraction of the amount of MC [medical cannabis] compared with other modes of delivery by inhalation. These outcomes were accompanied by a lower rate of AEs [adverse events] and almost no AE reports during a long-term steady-state follow-up. Additional follow-ups in a larger population is warranted to corroborate our findings,” the authors concluded.
For years, growers filed autoflowers under “easy but weak.” Hypno Seeds is one of the…
For decades, governments assumed poor people couldn’t be trusted with unconditional cash. A wave of…
The Washington State Department of Health just published a health advisory for FIFA World Cup…
During the Philadelphia leg of Kicking Back, Ethan Zohn follows soccer and cannabis from Massachusetts…
Three years after a ruptured artery in his lung nearly killed him, Krayzie Bone is…
Dave Sheridan played Officer Doofy in Scary Movie, the bumbling deputy ultimately revealed to be…